Natraj Proteins Limited Dispatches KYC Compliance Letters to Physical Shareholders on May 9, 2026

2 min read     Updated on 09 May 2026, 05:33 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Natraj Proteins Limited notified BSE Limited on May 9, 2026, that its RTA, M/s Ankit Consultancy Pvt. Ltd., has dispatched KYC letters to physical securities holders requiring PAN, nomination, contact details, bank account details, and specimen signature. The action is in compliance with multiple SEBI circulars, including the latest SEBI Circular HO/38/13/(4)2026-MIRSD-POD/I/4298/2026 dated February 06, 2026. Shareholders are reminded that effective April 1, 2024, all dividend, interest, and redemption payments for physical folios must be processed through electronic mode only. The filing was made under Regulation 30 of SEBI (LODR) Regulations, 2015.

powered bylight_fuzz_icon
39873833

*this image is generated using AI for illustrative purposes only.

Natraj Proteins Limited, a solvent extraction plant and refinery based in Itarsi, Madhya Pradesh, has notified BSE Limited of the dispatch of KYC compliance letters to its shareholders holding physical securities. The communication, filed on May 9, 2026, was submitted in compliance with Regulation 30 read with Schedule III Part A Para A Clause No. 12 of SEBI (LODR) Regulations, 2015.

KYC Dispatch and Regulatory Background

The company's Registrar and Share Transfer Agent (RTA), M/s Ankit Consultancy Pvt. Ltd., has dispatched letters to physical securities holders requesting mandatory submission of key KYC details. The dispatch is pursuant to SEBI circular dated November 03, 2021, subsequently amended by circulars dated December 14, 2021, March 16, 2023, November 17, 2023, and May 7, 2024, as well as SEBI Circular No. SEBI Circular HO/38/13/(4)2026-MIRSD-POD/I/4298/2026 dated February 06, 2026.

The following details are required from shareholders holding physical securities:

  • PAN – Permanent Account Number
  • Choice of Nomination – via Form SH-13, or opt-out via Form ISR-3
  • Contact Details – Postal address with PIN and mobile number (via Form ISR-1)
  • Bank Account Details – Bank and branch name, account number, and IFS code (via Form ISR-1)
  • Specimen Signature – via Form ISR-2

Electronic Payment Mandate Effective April 1, 2024

Shareholders are advised that effective April 1, 2024, all payments including dividend, interest, or redemption in respect of physical folios shall be routed through electronic mode only. Folios that do not have PAN, KYC details, and Nomination updated will face restrictions on grievance lodging and service requests with the RTA until the required documents are furnished.

Submission Modes and RTA Contact Details

Shareholders may submit the required documents through any one of the following modes:

  • In Person Verification (IPV): The authorized person of the RTA verifies original documents and retains copies with IPV stamping
  • Hard copies: Self-attested and dated copies submitted directly
  • Electronic mode: Submission with e-sign as elaborated under the SEBI circular

The relevant forms and SEBI circulars are available on the company's website and the RTA's website. Key form links are summarised below:

Form: Purpose
ISR-1 Registration/updation of contact and bank details
ISR-2 Specimen signature registration
ISR-3 Declaration to opt out of nomination
SH-13 Registration of nomination
SH-14 Cancellation or variation of nomination
ISR-4 Issuance of duplicate securities / other requests
ISR-5 Transmission of securities

The RTA contact details are as follows:

Parameter: Details
Name: M/s Ankit Consultancy Pvt. Ltd.
Address: 60, Electronic Complex, Pardeshipura, Indore (M.P.) - 452 010
Telephone: 0731-4065799, 4065797, 4949444
Email: investor@ankitonline.com
Website: www.ankitonline.com

The filing was signed by Harshita Kirkire, Company Secretary and Compliance Officer (M. No.: A77514), on behalf of Natraj Proteins Limited.

Historical Stock Returns for Natraj Proteins

1 Day5 Days1 Month6 Months1 Year5 Years
+6.83%-1.99%-1.73%-4.31%-8.46%-19.77%

What percentage of Natraj Proteins' physical securities holders are expected to remain non-compliant after the KYC deadline, and how might this affect the company's dividend distribution process?

How could SEBI's ongoing push to dematerialize physical securities impact smaller companies like Natraj Proteins in terms of shareholder base consolidation and administrative costs?

Will persistent non-compliance by physical folio holders potentially lead to SEBI mandating a complete freeze on trading or transfer of such securities in future regulatory updates?

Natraj Proteins Limited Confirms Non-Large Corporate Status Under SEBI Regulations for FY26

1 min read     Updated on 14 Apr 2026, 02:12 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Natraj Proteins Limited has confirmed to BSE that it does not qualify as a Large Corporate under SEBI regulations, exempting it from Annual Disclosure requirements for FY26. The confirmation was filed on April 14, 2026, by Company Secretary Harshita Kirkire, referencing SEBI Circular SEBI/HO/DDHS/CIR/P/2018/144 and its subsequent updates.

powered bylight_fuzz_icon
37701725

*this image is generated using AI for illustrative purposes only.

Natraj Proteins Limited has formally notified BSE Limited that it does not meet the criteria for classification as a Large Corporate under applicable SEBI regulations. The confirmation was filed on April 14, 2026, through BSE's online filing system.

Regulatory Compliance Status

The company has confirmed its non-Large Corporate status with reference to SEBI Circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. This circular was subsequently superseded by Circular No. SEBI/HO/DDHS/P/CIR/2021/613 dated August 10, 2021, read with BSE Notice No. 20220427-2 dated April 27, 2022.

Parameter Details
Filing Date April 14, 2026
Reference Circular SEBI/HO/DDHS/CIR/P/2018/144
Superseding Circular SEBI/HO/DDHS/P/CIR/2021/613
BSE Notice 20220427-2 dated April 27, 2022
Financial Year Ended March 31, 2026

Annual Disclosure Exemption

As a result of not meeting the Large Corporate criteria, Natraj Proteins Limited is exempt from filing the Annual Disclosure in Annexure B2 of the said circular for the year ended March 31, 2026. This exemption relieves the company from specific regulatory disclosure obligations that apply only to entities classified as Large Corporates under SEBI guidelines.

Filing Details

The confirmation was submitted by Company Secretary and Compliance Officer Harshita Kirkire, who holds membership number A77514. The document was digitally signed and filed through BSE's online portal at www.listing.bseindia.com . The company has requested BSE to place this information on its website for the reference of investors and members.

Corporate Information

Natraj Proteins Limited operates a solvent extraction plant and refinery located at Nagpur Kalan, Ordinance Factory Road, Itarsi. The company is incorporated under CIN L00153MP1990PLC006090 and trades on BSE under the code 530119.

Historical Stock Returns for Natraj Proteins

1 Day5 Days1 Month6 Months1 Year5 Years
+6.83%-1.99%-1.73%-4.31%-8.46%-19.77%

What are the potential growth strategies Natraj Proteins might pursue to eventually qualify as a Large Corporate under SEBI regulations?

How might the reduced regulatory disclosure requirements impact investor confidence and transparency perceptions for Natraj Proteins?

Could this non-Large Corporate status affect Natraj Proteins' ability to access capital markets or attract institutional investors?

More News on Natraj Proteins

1 Year Returns:-8.46%